RVTY
Revvity, Inc.Healthcare · $17.0B market cap
Verdict
Share price
$151.53
close of Oct 3, 2026
Fair value
$71.19
Sticker Price
Payback Price
$28.48
buy price
RVTY is Overpriced: at $151.53 it trades 113% above its fair value of $71.19. Its buy price (Payback Price) is $28.48, 81% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.
How we valued it
Free Cash Flow Growth. Free cash flow is growing faster than reported earnings, so we project free cash flow 10 years ahead instead.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow RVTY
Get notified when it reaches its buy price of $28.48. Free.
Create a free accountInsider activity
Since Jun 15, 2026: no open-market purchases, 1 sale worth $9K and 5 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Other filings
MICHAS ALEXIS P
director · 2026-08-25
G-Gift
285 shares
Goldberg Joel S
Please See Remarks · 2026-08-14
G-Gift
27,785 shares
Singh Prahlad R.
Please See Remarks · 2026-08-13
G-Gift
59,650 shares
Singh Prahlad R.
Please See Remarks · 2026-08-13
G-Gift
7,636 shares
Gonzales Anita
Vice President and CAO · 2026-06-15
Tax withholding
$3K
About Revvity, Inc.
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents…
Medical - Diagnostics & Research
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works